date:Feb 26, 2013
ChromaDex will continue to generate revenue through a royalty on future net sales of BluScience products as well as a supply agreement with NeutriSci for its patented pTeroPure pterostilbene, which will continue to be the key active ingredient in the BluScience product line. ChromaDex will retain all rights and ownership to its pTeroPure pterostilbene.
NeutriSci president and CEO Keith Bushfield said that BluScience offers a clinically proven product line backed by strong scientific research a